TuHURA Biosciences HURA
NASDAQ HURA
$1.91 -0.07 (-3.54%)
At close: Oct 2, 2026 · 4:00 PM EDT

TuHURA Biosciences (HURA) Other Accumulated Expenses (2023 - 2024)

Updated

TuHURA Biosciences (HURA) reported Other Accumulated Expenses of $52,000 for FY2024.

Analysis

TuHURA Biosciences (HURA) Other Accumulated Expenses (2023 - 2024) Analysis & Trends

  • According to Business Quant data, Other Accumulated Expenses came in at $148,000 in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 TuHURA Biosciences 35.65 Mn 35.65 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 50,000.00
Jun 30, 2024 52,000.00
Mar 31, 2024 98,000.00
Dec 31, 2023 148,000.00
Sep 30, 2023 338,000.00
Jun 30, 2023 298,000.00
API Access

TuHURA Biosciences Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=HURA&period=max&api_key=YOUR_API_KEY